These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical aspects of anticholinergic agents]. Friedman M Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345 [No Abstract] [Full Text] [Related]
4. A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD. Teramoto S; Fukuchi Y; Ouchi Y Chest; 1996 Jun; 109(6):1666-7. PubMed ID: 8769538 [No Abstract] [Full Text] [Related]
5. Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD? Blosser SA; Maxwell SL; Reeves-Hoche MK; Localio AR; Zwillich CW Chest; 1995 Sep; 108(3):730-5. PubMed ID: 7656624 [TBL] [Abstract][Full Text] [Related]
6. [COPD treatment by drugs]. Nafti S Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967 [No Abstract] [Full Text] [Related]
8. Anticholinergic bronchodilators. Witek TJ Respir Care Clin N Am; 1999 Dec; 5(4):521-36. PubMed ID: 10565879 [TBL] [Abstract][Full Text] [Related]
9. Apples and oranges : flaws and guffaws. Petty TL Chest; 1999 Oct; 116(4):1137-8. PubMed ID: 10531190 [No Abstract] [Full Text] [Related]
10. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease. Colice GL Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712 [TBL] [Abstract][Full Text] [Related]
11. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease. Friedman M Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715 [TBL] [Abstract][Full Text] [Related]
12. Beta-agonists in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Kuhl DA; Agiri OA; Mauro LS Ann Pharmacother; 1994 Dec; 28(12):1379-88. PubMed ID: 7696730 [TBL] [Abstract][Full Text] [Related]
13. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD. Ikeda A; Nishimura K; Izumi T Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208 [No Abstract] [Full Text] [Related]
14. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients. Pillet O; Manier G; Castaing Y Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900 [TBL] [Abstract][Full Text] [Related]
15. [Current strategy of bronchodilator therapy for chronic obstructive pulmonary disease (COPD)]. Teramoto S Nihon Rinsho; 1999 Sep; 57(9):2051-5. PubMed ID: 10497405 [TBL] [Abstract][Full Text] [Related]
16. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD. Ingram RH Chest; 1996 Jan; 109(1):293. PubMed ID: 8549206 [No Abstract] [Full Text] [Related]
17. An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations. Woods JA; Usery JB; Self TH; Finch CK South Med J; 2011 Nov; 104(11):742-5. PubMed ID: 22024782 [TBL] [Abstract][Full Text] [Related]
18. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Griffiths B; Ducharme FM Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133 [TBL] [Abstract][Full Text] [Related]
19. Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department? Koutsogiannis Z; Kelly AM Aust N Z J Med; 2000 Feb; 30(1):38-40. PubMed ID: 10800876 [TBL] [Abstract][Full Text] [Related]
20. Teaching correct use of inhaled medications. Rokosky JM Home Healthc Nurse; 2005 Dec; 23(12):766-74; quiz 775-6. PubMed ID: 16331059 [No Abstract] [Full Text] [Related] [Next] [New Search]